Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)

Q: What does CUSIP 75943R102 represent in this 13F holders report?

CUSIP 75943R102 is the security identifier for RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q4 2023?

176 institutional investors reported RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 75943R102

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 4,389,099
Total 13F shares: 127,244,702
Share change: -3,476,791
Total reported value: $1,400,985,578
Put/Call ratio: 384%
Price per share: $11.01
Number of holders: 176
Value change: -$17,110,979
Number of buys: 80
Number of sells: 81

Quarterly Holders Quick Answers

What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 75943R102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SB INVESTMENT ADVISERS (UK) LTD	13F	Company	636%	27,904,963	$234,680,739	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	240%	10,552,362	$88,745,365	—	30 Sep 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	196%	8,608,946	$72,403,000	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	190%	8,329,767	$70,053,341	—	30 Sep 2023	13F
Casdin Capital, LLC	13F	Company	158%	6,923,574	$58,227,257	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	117%	5,136,484	$43,197,830	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	112%	4,906,589	$41,264,413	—	30 Sep 2023	13F
Bellevue Group AG	13F	Company	111%	4,885,000	$41,082,850	—	30 Sep 2023	13F
EcoR1 Capital, LLC	13F	Company	95%	4,163,824	$35,017,760	—	30 Sep 2023	13F
ArrowMark Colorado Holdings LLC	13F	Company	87%	3,810,579	$32,046,969	—	30 Sep 2023	13F
BVF INC/IL	13F	Company	54%	2,365,805	$19,896,420	—	30 Sep 2023	13F
T. Rowe Price Investment Management, Inc.	13F	Company	52%	2,263,360	$19,035,000	—	30 Sep 2023	13F
FMR LLC	13F	Company	48%	2,107,733	$17,726,035	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	45%	1,970,988	$16,577,979	—	30 Sep 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	44%	1,943,097	$16,341,445	—	30 Sep 2023	13F
Boxer Capital, LLC	13F	Company	41%	1,819,132	$15,298,900	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	38%	1,682,849	$14,152,760	—	30 Sep 2023	13F
Alphabet Inc.	13F	Company	36%	1,568,753	$13,193,212	—	30 Sep 2023	13F
NORGES BANK	13F	Company	34%	1,506,828	$12,672,423	—	30 Sep 2023	13F
MPM BioImpact LLC	13F	Company	31%	1,352,133	$11,371,439	—	30 Sep 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	28%	1,241,475	$10,440,805	—	30 Sep 2023	13F
Nextech Invest Ltd.	13F	Company	27%	1,196,409	$10,061,800	—	30 Sep 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	26%	1,160,117	$9,756,584	—	30 Sep 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	23%	1,017,668	$8,557,862	—	30 Sep 2023	13F
S.c.a. Candriam	13F	Individual	22%	971,070	$8,166,699	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	22%	958,198	$8,058,445	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	20%	891,605	$7,498,398	—	30 Sep 2023	13F
Finepoint Capital LP	13F	Company	20%	870,870	$7,324,017	—	30 Sep 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	20%	865,455	$7,278,477	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	18%	801,358	$6,739,421	—	30 Sep 2023	13F
Integral Health Asset Management, LLC	13F	Company	18%	800,000	$6,728,000	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	16%	714,805	$6,011,510	—	30 Sep 2023	13F
Rock Springs Capital Management LP	13F	Company	15%	673,966	$5,668,054	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	15%	657,541	$5,529,921	—	30 Sep 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	14%	593,002	$4,987,147	—	30 Sep 2023	13F
BESSEMER GROUP INC	13F	Company	13%	584,463	$4,915,000	—	30 Sep 2023	13F
ORBIMED ADVISORS LLC	13F	Company	11%	501,966	$4,221,534	—	30 Sep 2023	13F
TD ASSET MANAGEMENT INC	13F	Company	11%	497,490	$4,183,891	—	30 Sep 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	9.1%	400,673	$3,369,660	—	30 Sep 2023	13F
BAILLIE GIFFORD & CO	13F	Company	9%	394,450	$3,317,324	—	30 Sep 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	8.8%	384,536	$3,233,946	—	30 Sep 2023	13F
Rafferty Asset Management, LLC	13F	Company	8.6%	377,745	$3,176,835	—	30 Sep 2023	13F
Jefferies Financial Group Inc.	13F	Company	8.3%	362,609	$3,049,542	—	30 Sep 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	7.6%	335,071	$2,817,947	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	7.3%	322,520	$2,712,393	—	30 Sep 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	7%	305,200	$2,566,732	—	30 Sep 2023	13F
HARBOURVEST PARTNERS LLC	13F	Company	6.8%	296,402	$2,492,741	—	30 Sep 2023	13F
HighTower Advisors, LLC	13F	Company	6.5%	285,343	$2,398,000	—	30 Sep 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	6.4%	279,115	$2,347,357	—	30 Sep 2023	13F
TWINBEECH CAPITAL LP	13F	Company	6%	265,344	$2,231,543	—	30 Sep 2023	13F

Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY) as of Q4 2023

As of 31 Dec 2023, Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY) was held by 176 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 127,244,702 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Casdin Capital, LLC, JPMORGAN CHASE & CO, Bellevue Group AG, STATE STREET CORP, BVF INC/IL, and ArrowMark Colorado Holdings LLC. This page lists 176 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

169

Q4 2023 holders

176

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.